Aridis Pharmaceuticals In...
(ARDS) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.00
-99.00%
Pre-market Oct 07, 2024, 09:30 AM EDT
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 4.88M | 19.99M | 8.23M | 20.90M | 24.24M | 25.10M | 22.29M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 9.00K | 960.00K | n/a | n/a |
Other Long-Term Assets | 905.00K | -1.38M | -1.28M | -1.05M | 7.37M | 345.00K | 41.00K |
Receivables | 1.24M | 237.00K | 368.00K | 413.00K | 2.10M | n/a | 67.00K |
Inventory | n/a | -237.00K | -368.00K | -413.00K | -4.11M | n/a | n/a |
Other Current Assets | 5.51M | 6.05M | 4.16M | 4.53M | 2.01M | 244.00K | 51.00K |
Total Current Assets | 11.63M | 26.80M | 15.12M | 27.97M | 24.24M | 25.34M | 22.41M |
Property-Plant & Equipment | 2.15M | 1.36M | 1.26M | 1.01M | 1.27M | 750.00K | 39.00K |
Goodwill & Intangibles | 17.00K | 22.00K | 27.00K | 32.00K | 38.00K | 43.00K | 48.00K |
Total Long-Term Assets | 3.07M | 2.31M | 2.27M | 1.60M | 7.37M | 1.14M | 128.00K |
Total Assets | 14.70M | 26.80M | 15.12M | 27.97M | 31.61M | 26.48M | 22.54M |
Account Payables | 2.31M | 5.24M | 1.89M | 1.75M | 2.33M | 933.00K | 678.00K |
Deferred Revenue | 20.17M | 20.84M | 18.75M | 14.60M | 22.00K | 120.00K | n/a |
Short-Term Debt | 4.84M | 696.00K | 439.00K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 9.58M | 6.57M | 1.37M | 2.97M | 2.94M | 2.12M | 1.72M |
Total Current Liabilities | 36.90M | 33.35M | 22.44M | 19.33M | 5.30M | 3.17M | 2.40M |
Long-Term Debt | 1.29M | 5.28M | 276.00K | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 363.00K | 228.00K | n/a | n/a | 11.87M | 6.37M |
Total Long-Term Liabilities | 2.03M | 6.56M | 1.36M | 5.00M | n/a | 11.87M | 6.37M |
Total Liabilities | 38.93M | 40.91M | 23.80M | 24.33M | 5.30M | 15.04M | 8.76M |
Total Debt | 6.13M | 5.98M | 715.00K | n/a | n/a | n/a | n/a |
Common Stock | 3.00K | 2.00K | 1K | 1K | 1K | n/a | n/a |
Retained Earnings | -195.67M | -165.29M | -123.10M | -100.77M | -71.09M | -47.63M | -20.18M |
Comprehensive Income | 5.05M | n/a | n/a | n/a | -491.00K | -215.00K | -158.00K |
Shareholders Equity | -24.23M | -14.11M | -8.68M | 3.64M | 26.31M | 11.44M | 13.78M |
Total Investments | n/a | n/a | n/a | 9.00K | 960.00K | n/a | n/a |